Table 3 Characteristics of demographic and clinical features of the patients after IPTW
Variables | PLT > 49.5 × 10^9/L (n = 167) | PLT ≤ 49.5 × 10^9/L (n = 162) | P value |
|---|---|---|---|
Donor features | |||
 Donor age (years) | 47.04 ± 1.15 | 46.58 ± 1.26 | 0.772 |
 Donor gender (male, %) | 152 (86.4%) | 120 (86.3%) | 0.993 |
 Donor BMI (kg/m2) | 22.49 (20.52, 24.22) | 22.86 (20.64, 24.69) |  |
Demographic features | |||
 Age (years) | 47.39 ± 0.70 | 45.30 ± 0.87 |  |
 Gender (male, %) | 136 (77.3%) | 109 (78.4%) | 0.808 |
 BMI (kg/m2) | 22.80 (20.20, 24.22) | 22.05 (19.68, 24.32) | 0.542 |
Clinical features | |||
 Preoperative laboratory values | |||
 Creatinine (μmol/L) | 59.72 (44.74, 72.00) | 56.00 (47.00, 66.37) | 0.552 |
 BUN (mmol/L) | 4.40 (3.38, 6.93) | 4.77 (3.88, 6.10) | 0.954 |
 Red cell (×1012/L) | 3.57 (3.04, 4.01) | 3.29 (2.82, 3.97) | 0.012 |
 Leukocyte (×109/L) | 3.57 (2.77, 5.43) | 3.27 (2.35, 5.37) | 0.119 |
 Lymphocyte (×109/L) | 0.58 (0.45, 1.03) | 0.53 (0.34, 0.89) | 0.351 |
 ALT (U/L) | 35.11 (21.00, 70.00) | 30.37 (23.96, 48.59) | 0.669 |
 AST (U/L) | 44.00 (31.00, 85.00) | 42.66 (29.00, 63.00) | 0.915 |
 Total bilirubin (μmol/L) | 41.73 (23.85, 110.03) | 55.20 (28.76, 114.20) | 0.333 |
 Albumin (g/L) | 36.82 (32.71, 41.80) | 35.75 (31.80, 41.14) | 0.190 |
 PT (s) | 18.14 (15.51, 21.42) | 18.50 (16.90, 21.80) | 0.389 |
 APTT (s) | 45.00 (39.50, 50.20) | 47.25 (41.76, 52.22) | 0.904 |
Hepatic features | |||
 MELD | 12.00 (6.74, 19.15) | 13.00 (9.00, 17.00) | 0.713 |
Etiology | Â | Â | 0.298 |
 Viral hepatitis (%) | 84 (47.7%) | 83 (59.7%) |  |
 Alcoholic cirrhosis (%) | 6 (3.4%) | 3 (2.2%) |  |
 Hepatocellular Carcinoma (%) | 53 (30.1%) | 33 (23.7%) |  |
 Primary biliary cirrhosis & Autoimmune liver disease (%) | 9 (5.1%) | 7 (5.0%) |  |
 Other (%) | 24 (13.6%) | 13 (9.4%) |  |
Coexisting conditions | |||
 Smoking (%) | 64 (36.4%) | 39 (28.1%) | 0.119 |
 Drinking (%) | 45 (25.6%) | 29 (20.9%) | 0.328 |
 Hypertension (%) | 11 (6.3%) | 4 (2.9%) | 0.259 |
 Diabetes (%) | 14 (8.0%) | 14 (10.1%) | 0.512 |
 Pre-operative PVT (%) | 33 (18.6%) | 18 (12.9%) | 0.172 |
 Pre-operative splenectomy (%) | 12 (6.8%) | 8 (5.8%) | 0.701 |
Intraoperative factors | |||
 Operation time (min) | 389.33 (330.00, 470.00) | 386.43 (340.00, 424.11) | 0.296 |
 Anhepatic phase (min) | 49.00 (44.00, 57.00) | 49.00 (45.00, 57.00) | 0.285 |
 Intraoperative blood loss (mL) | 1500.00 (800.00, 3000.00) | 1500.00 (800.00, 2573.16) | 0.564 |
 Total input amount (mL) | 6072.43 (4785.37, 7820.00) | 6000.00 (5120.00, 7913.63) | 0.947 |
 Warm ischemia time (min) | 12.00 (6.74, 19.15) | 13.00 (9.00, 17.00) | 0.617 |
 Cold ischemia time (h) | 6.00 (5.00, 6.00) | 6.00 (4.00, 6.00) | 0.476 |